Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients

Despite the advancement of epidermal growth factor receptor (EGFR) inhibitors in lung cancer therapy, it remains unclear whether EGFR mutation status in familial lung cancers is different from that of sporadic cases. In this multicenter retrospective study, we compared both the EGFR mutation frequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Kuo-Hsuan, Tseng, Jeng-Sen, Wang, Chih-Liang, Yang, Tsung-Ying, Tseng, Chien-Hua, Chen, Hsuan-Yu, Chen, Kun-Chieh, Tsai, Chi-Ren, Yang, Cheng-Ta, Yu, Sung-Liang, Su, Kang-Yi, Yu, Chong-Jen, Ho, Chao-Chi, Hsia, Te-Chun, Wu, Ming-Fang, Chiu, Kuo-Liang, Liu, Chien-Ming, Yang, Pan-Chyr, Chen, Jeremy J.W., Chang, Gee-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288187/
https://www.ncbi.nlm.nih.gov/pubmed/27449093
http://dx.doi.org/10.18632/oncotarget.10715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288187/
https://www.ncbi.nlm.nih.gov/pubmed/27449093
http://dx.doi.org/10.18632/oncotarget.10715

Ejemplares similares